AdvantaSil silicone tubing and hose products are quickly becoming recognized as superior products for single-use processes worldwide. Engineers in process development and manufacturing have relied on AdvantaSil products for years for unreinforced tubing, reinforced hose, pump grade tubing and wire reinforced suction hose. The products are designed and tested for the biopharmaceutical and pharmaceutical industries and are used for food, beverage, laboratory and chemical transfer applications as well. Previously, the products were typically referred to by their part number nomenclature…
Author Archives: BPI Contributor
Roquette Commits to BioPharma Market
Roquette, a global leader in innovative plant-based pharmaceutical ingredients, announces its commitment to provide new product offerings to address the growing demand for excipients and raw materials for the biopharmaceutical market. New product offerings are low endotoxin, multi-compendial grade materials for cell culture and biologic drug formulations. These products extend Roquette’s commitment to helping customers save and sustain patient’s lives. “As a long-time leader in excipients and active ingredients for the pharmaceutical market, Roquette is proud to be part of…
Tosoh Bioscience Introduces TOYOPEARL® AF-rProtein L-650F Process Chromatography Resin
Tosoh Bioscience LLC, a provider of chromatographic resins for the purification of biopharmaceutical drugs in commercial manufacturing processes, today announced the introduction of TOYOPEARL AF-rProtein L-650F, a Protein L resin that exhibits the highest binding capacity for antibody fragments that lack a Fc-portion (e.g. Fab, ScF Dab, etc.). TOYOPEARL AF-rProtein L-650F resin is now available for sale in the Americas from Tosoh Bioscience LLC. TOYOPEARL AF-rProtein L-650F resin does not only offer the highest binding capacity, but also has the…
MilliporeSigma’s Integritest® 5 Instrument Provides Integrity Testing, Assurance
MilliporeSigma’s new Integritest® 5 instrument is an easy-to-use, portable and fully automated integrity test system for verification of filters and processing equipment. The latest model of the first commercially available automated integrity test instrument introduced more than 25 years ago now incorporates an improved algorithm to simplify test creation and accelerate test completion. The user-friendly software makes it easy to set up and manage users and tests, while offering a depth of advanced functionality for those who need additional options.…
Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
Sanofi and Lonza announced today that they have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. The strategic partnership in the form of a joint venture combines the strong biologics development pipeline of Sanofi with the expertise of Lonza to design, construct, start-up and operate a state-of-the-art large-scale mammalian cell culture facility. The initial investment will be around CHF 290 million (€ 270 million), to be…
Distek, Inc. Releases Eclipse 5300 Automated Dissolution Sampler
Distek, Inc., a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry, as well as an experienced provider of validation and qualification services, announced today the release of the Eclipse 5300 automated dissolution sampler. The Eclipse 5300 Automated Dissolution Sampler by Distek offers rapid and accurate sampling using precision syringes. The elimination of valves and rotary pumps along with the short sample pathway and minimal dead volume increases reliability while eliminating and reducing common sources of sample…
Filling Industry Gaps with Dedicated Cell Therapy Fluid Transfer Sets
For years, availability has cornered cell therapy manufacturers into utilizing transfer sets intended for other industries and applications. These transfer sets or accessory sets are not designed for cell therapy, and therefore lack key requirements, essential to clinical and commercial manufacturing. Many current personalized cell therapies are highly manual in practice, and require numerous ancillary components and handling steps. Modifications to these processes further complicate this inherently challenging process. These deviations impact the reproducibility of the manufacturing platform, as well…
Lonza and Selecta Biosciences Announce Manufacturing Agreement for Anc80-AAV-Based Gene Therapy for Treatment of Methylmalonic Acidemia
Lonza Houston, Inc., a global leader in viral gene and cell therapy manufacturing, and Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company focused on developing biologic therapies for rare and serious diseases that avoid unwanted immunogenicity, have entered into a strategic manufacturing agreement. Under the terms of the agreement, Lonza will produce an Anc80-AAV-based gene therapy product for Selecta’s proprietary program for the treatment of Methylmalonic Acidemia (MMA), a rare inborn error of metabolism, and may in the future produce other…
Almatec® Featuring BIOCOR Series Pumps at INTERPHEX 2017
Almatec®, part of PSG®, a Dover company and premier manufacturer of sanitary air-operated double-diaphragm (AODD) pumps, will be featuring its BIOCOR Series pumps for sterile applications in Booth 2253 at INTERPHEX 2017. The INTERPHEX event brings together a wide variety of leaders from the pharmaceutical and biotech industries and will be held at the Jacob K. Javits Convention Center in New York, NY, USA, from March 21-23. BIOCOR pumps from Almatec have been specifically designed for critical biotech and pharmaceutical…
Rentschler and Leukocare Announce Formulations Strategic Alliance and Equity Investment
Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance under which Leukocare will become the specialized technology partner and the exclusive formulation developer for Rentschler’s biopharmaceuticals business. Rentschler in return will become the first and only contract development and manufacturing organization (CDMO) to have access to Leukocare´s patented SPS® formulation technologies. Leukocare’s ongoing and future business activities with pharma and biotech beyond the CDMO business will not be affected by this alliance. Rentschler will acquire a…